SCHEMBL13985609

SCHEMBL13985609

N#Cc1cc(-c2c(F)c(F)c(-c3cccc4c3ccc3cc5ccccc5cc34)c(F)c2F)cc(C#N)c1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.38
PIM1 P11309 2/20 0.37
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
ANPEP P15144 1/20 0.36
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
PDE9A O76083 1/20 0.34
KDM4E B2RXH2 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HIF1A Q16665 1/20 0.32
CYP1B1 Q16678 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
DHODH Q02127 1/20 0.31
SQOR Q9Y6N5 1/20 0.31
ERBB2 P04626 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8780567 0.92 MCL1 (0.41) MCL1PIM1ESR1ESR2ANPEP
SCHEMBL9612380 0.89 MCL1 (0.37) MCL1PIM1ESR1ESR2CYP11B1
SCHEMBL13249122 0.81 DHODH (0.34) MCL1ESR1ESR2ANPEPCYP11B1
SCHEMBL29110487 0.75 CA1 (0.38) MCL1PIM1ANPEPPDE9AKDM4E
SCHEMBL16122068 0.71 MCL1 (0.50) MCL1PIM1ESR1ESR2CYP11B1
SCHEMBL8780578 0.71 ALDH1A1 (0.47) ALDH1A1HIF1ACYP1B1HSD17B10ERBB2
SCHEMBL17197648 0.71 CA1 (0.40) PIM1ESR1ESR2PDE9ACA1
SCHEMBL2551156 0.71 ALDH1A1 (0.52) ANPEPKDM4EALDH1A1HIF1ACYP1B1
SCHEMBL2709174 0.71 CES1 (0.41) KDM4EALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL29489130 0.69 MCL1 (0.47) MCL1PIM1ANPEPKDM4ECA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
WO-2011012212-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2011-02-03 WO disclosed
WO-2008145239-A2 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MYB, L1CAM, SLC25A21 MCL1 3912/4885PIM1 2050/4885ESR1 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.